Search Within

Arjun Vasant Balar

  1. "Surgery"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. Genitourinary Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Surgery (5)
  5. Urology (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Bernard Bochner (5)
  2. Dean Bajorin (5)
  3. Gopakumar Iyer (5)
  4. Hikmat Al-Ahmadie (4)
  5. Irina Ostrovnaya (4)
  6. David Solit (3)

More People

Years
  1. 2021 (1)
  2. 2013 (1)
  3. 2012 (2)
  4. 2011 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Journal of Pathology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Wiley Blackwell (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial
    Meeting Abstract

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
    Journal Article

    Iyer, G.; Al-Ahmadie, H.; Schultz, N.; Hanrahan, A. J.; Ostrovnaya, I.; Balar, A. V.; Kim, P. H.; Lin, O.; Weinhold, N.; Sander, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Apolo, A. B.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Ostrovnaya, I.; Chou, J. F.; Bochner, B.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Al-Ahmadie, H.; Janakiraman, M.; Ostrovnaya, I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Bochner, B.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Journal Article

    Al-Ahmadie, H. A.; Iyer, G.; Janakiraman, M.; Lin, O.; Heguy, A.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Balar, A.; more...
    Journal of Pathology (2011)

    Fulltext@MSK | Save